UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported 5/24/2005)
Med Gen Inc.
----------------------------------------------------
(Exact name of registrant as specified in its charter)
Nevada 000-29171 65-0703559
- --------------------------- ---------------- -------------------
(State or other Jurisdiction (Commission File (IRS Employer
of incorporation) Number) Identification No.)
7284 West Palmetto Park Road, Suite #207, Boca Raton, FL 33433
- -------------------------------------------------------------------------
(Address of principal executive offices)
561-750-1100
- -------------------------------------------------------------------------
(Issuer's telephone number)
Not Applicable
- -------------------------------------------------------------------------
(Former name or former address, if changed since last report)
All Correspondence to:
Paul B Kravitz CEO
C/O Med Gen Inc.
7284 West Palmetto Park Road
Suite #207
Boca Raton, FL 33433
Item 8.01 Other Events.
On May 23rd, 2005 the Company filed an amended SB-2 Registration
Statement covering the issuance of up to 206,428,728 shares of common
stock. The Company has extended its proxy date to June 23rd, 2005 so
that all shareholders of record can review the filing and then vote on
the amendment to increase the authorized capital from 50,000,000
to 250,000,000. A copy of the Amended Registration Statement will be
mailed to shareholders of record pursuant to the terms of the
Definitive Proxy which is already on file with the S.E.C.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned hereunto duly authorized.
Med Gen Inc.
Date: May 24, 2005
/s/Paul B. Kravitz
----------------------------------
Paul B. Kravitz,
Chairman & Chief Executive Officer